150 related articles for article (PubMed ID: 33608396)
1. Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin YS; Lin SC; Hsieh YT; Liu LY; Lin CH; Shen LJ; Huang CF
Eur J Hosp Pharm; 2022 Nov; 29(6):324-328. PubMed ID: 33608396
[TBL] [Abstract][Full Text] [Related]
2. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
[TBL] [Abstract][Full Text] [Related]
3. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
4. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
Cober MP; Johnson CE
Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
[TBL] [Abstract][Full Text] [Related]
5. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
6. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
7. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
8. Stability of extemporaneously prepared rufinamide oral suspensions.
Hutchinson DJ; Liou Y; Best R; Zhao F
Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
[TBL] [Abstract][Full Text] [Related]
9. Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP; Johnson CE; Lee J; Currie K
Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
[TBL] [Abstract][Full Text] [Related]
10. Stability of dolasetron in two oral liquid vehicles.
Johnson CE; Wagner DS; Bussard WE
Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
[TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
12. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
[TBL] [Abstract][Full Text] [Related]
13. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
Zhang YP; Trissel LA; Fox JL
Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
[TBL] [Abstract][Full Text] [Related]
14. Extemporaneous suspension of propafenone: attending lack of pediatric formulations in Mexico.
Juárez Olguín H; Flores Pérez C; Ramírez Mendiola B; Coria Jiménez R; Sandoval Ramírez E; Flores Pérez J
Pediatr Cardiol; 2008 Nov; 29(6):1077-81. PubMed ID: 18587605
[TBL] [Abstract][Full Text] [Related]
15. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
[TBL] [Abstract][Full Text] [Related]
16. Stability of sotalol hydrochloride in extemporaneously prepared oral suspension formulations.
Sidhom MB; Rivera N; Almoazen H; Taft DR; Kirschenbaum HL
Int J Pharm Compd; 2005; 9(5):402-6. PubMed ID: 23925139
[TBL] [Abstract][Full Text] [Related]
17. Stability of sotalol in two liquid formulations at two temperatures.
Nahata MC; Morosco RS
Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
[TBL] [Abstract][Full Text] [Related]
18. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
[TBL] [Abstract][Full Text] [Related]
19. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
Nahata MC; Morosco RS; Hipple TF
Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
[TBL] [Abstract][Full Text] [Related]
20. Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
